| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.71B | 6.57B | 6.27B | 6.36B | 6.32B | 5.74B |
| Gross Profit | 4.73B | 4.61B | 4.43B | 4.21B | 4.22B | 3.81B |
| EBITDA | 1.79B | 1.69B | 1.58B | 1.43B | 1.36B | 1.29B |
| Net Income | 1.21B | 1.19B | 986.00M | 1.27B | 937.00M | 730.00M |
Balance Sheet | ||||||
| Total Assets | 9.97B | 10.82B | 9.89B | 9.82B | 10.03B | 9.36B |
| Cash, Cash Equivalents and Short-Term Investments | 3.02B | 3.85B | 3.25B | 3.07B | 4.13B | 4.60B |
| Total Debt | 2.73B | 3.49B | 2.65B | 2.68B | 2.94B | 2.75B |
| Total Liabilities | 8.81B | 9.78B | 8.74B | 8.66B | 9.19B | 8.68B |
| Stockholders Equity | 1.16B | 1.04B | 1.15B | 1.16B | 838.00M | 685.00M |
Cash Flow | ||||||
| Free Cash Flow | 1.61B | 1.34B | 1.53B | 868.00M | 985.00M | 1.17B |
| Operating Cash Flow | 1.79B | 1.51B | 1.69B | 1.11B | 1.21B | 1.33B |
| Investing Cash Flow | -728.00M | 147.00M | -735.00M | -1.39B | -561.00M | 21.00M |
| Financing Cash Flow | -968.00M | -828.00M | -1.34B | -1.51B | -1.02B | 444.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $136.97B | 8.79 | 64.18% | 0.18% | -31.20% | 149.53% | |
72 Outperform | $127.85B | 26.06 | -889.39% | 1.02% | 25.18% | 65.02% | |
64 Neutral | $21.45B | 14.44 | 116.57% | 1.89% | 3.04% | 9.12% | |
63 Neutral | $17.42B | 10.90 | 13.33% | ― | 35.06% | -43.22% | |
62 Neutral | $18.10B | 8.26 | 1135.29% | 5.09% | 5.09% | -5.05% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |